SenzaGen AB
SSE:SENZA.ST
6.7 (SEK) • At close February 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SenzaGen AB |
Symbool | SENZA.ST |
Munteenheid | SEK |
Prijs | 6.7 |
Beurswaarde | 161,234,830 |
Dividendpercentage | 0% |
52-weken bereik | 6.08 - 13.1 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Peter Nahlstedt |
Website | https://senzagen.com |
An error occurred while fetching data.
Over SenzaGen AB
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)